Category Human Rights

UN Global Dialogue On Innovation And Access To Medicines This Week

The United Nations Secretary General’s High-Level Panel on Access to Medicines is holding a global dialogue this month, attended by governments, civil society, industry and academia, to discuss potential solutions to promote innovation and at the same time increase access to medicines. The first public dialogue session is this week, on 10 March in London.

Apple-FBI Case Has “Serious Global Ramifications,” UN Human Rights Chief Says

The United Nations High Commissioner for Human Rights, Zeid Ra'ad Al Hussein, today issued a statement urged United States law enforcement authorities to exercise caution in their legal fight against Apple computer company, saying it could have "extremely damaging implications for the human rights of many millions of people, including their physical and financial security."

Alleged R&D Costs: Not A Transparent Driver Of Drug Prices

Whether laws enforcing transparency on costs would help curb extortionate drug prices in today’s world is hardly predictable now that pharma companies and their allies are lobbying governments to scupper any rules that would require them to disclose the real R&D costs and profits of their medicines and the rationale for charging what they do, writes Daniele Dionisio.

Questions Over WIPO Statements At UN Secretary-General’s Panel On Access To Medicines

The World Intellectual Property Organization, a specialized agency of the United Nations, was unique among Geneva-based UN agencies for offering views at both recent meetings of the UN High-Level Panel on Access to Medicines held in Geneva and New York this month. Now WIPO has come under criticism from public health advocates for the views it gave.

Vision, Urgency Of UN High-Level Panel On Access To Medicines Begins To Take Shape

NEW YORK -- It came as a surprise to some when the United Nations Secretary General’s office announced in November the setting up of a high level panel to urgently address access to medicines and other health technologies. After all, UN agencies in Geneva, most notably the World Health Organization, have been working on these issues for years. Yesterday at the UN in New York, an event was held to explain some of the vision and urgency behind the setting up of the panel, which includes an expert committee of representatives of some 10 international organisations and others. It also includes an open online call for contributed ideas until 18 February, and two public hearings.

Special Feature: WHO Still On Trail Of New Financing For R&D For Poor Populations’ Medical Needs

World Health Organization members are expected to meet this spring to assess progress and discuss potential solutions to the lack of financing for research and development for diseases affecting primarily developing countries. The WHO Executive Board last week discussed and noted a report by the WHO secretariat for the preparation of the open-ended meeting. The exact date of the meeting is not certain, according to WHO officials, but would likely be in March or April.

200 Companies, Organisations Worldwide Promote Stronger Encryption

Nearly 200 organisations, companies and others from 42 countries have signed an open letter to the international community demanding that stronger encryption tools be allowed to be developed and used. The letter describes encryption tools and services as vital components of maintaining a secure digital environment, where if users are allowed to use the strongest forms of encryption it can allow for the safest and most efficient ways to communicate across borders.

Special Feature: UN High Level Panel On Access To Medicines – First Reactions, Process Explained

A high level panel of experts charged by United Nations secretary general to explore solutions to increase innovation and access to medicines in developing countries gave a briefing today to explain the process of the initiative. Intellectual property is often seen as both a barrier to the diffusion of health technologies and an innovation enabler.

Evaluation Starts On WHO Global Strategy For Public Health, Innovation, IPRs

This morning, World Health Organization Executive Board members took note of a report by the WHO secretariat on the evaluation of the organisation’s global strategy and plan of action on public health, innovation and intellectual property. An inception report by the evaluation team was provided to the WHO in December, which has not been shared to the member states, according to the secretariat, although its results are expected to be presented to them in March. In the meantime, key points have been provided.